Treatment-stage migration maximizes survival outcomes in patients with hepatocellular carcinoma treated with sorafenib: an observational study
Author(s)
Type
Conference Paper
Date Issued
2017-01-01
Date Acceptance
2016-12-27
Citation
JOURNAL OF HEPATOLOGY, 2017, 66 (1), pp.S223-S224
ISSN
0168-8278
Publisher
ELSEVIER SCIENCE BV
Start Page
S223
End Page
S224
Journal / Book Title
JOURNAL OF HEPATOLOGY
Volume
66
Issue
1
Copyright Statement
© 2017European Association for the Study of the Liver (EASL)
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000401056600482&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Source
International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver
Subjects
Science & Technology
Life Sciences & Biomedicine
Gastroenterology & Hepatology
Publication Status
Published
Start Date
2017-04-19
Finish Date
2017-04-23
Coverage Spatial
Amsterdam, NETHERLANDS